Doberneck R C
Ann Surg. 1980 Aug;192(2):152-6. doi: 10.1097/00000658-198008000-00003.
The entry of third party payors into the field of health care has brought about increasing awareness of cost-effectiveness. Since breast biopsy is among the most commonly performed operations and open to criticism, the purpose of this report is to provide data relative to cost-effectiveness of breast biopsies at the University of New Mexico and to compare such data with 1) cost-effectiveness of mammographic screening for breast cancer, and 2) cost-effectiveness of judicious use of mammography in patients with breast complaints. From 1972 through 1978, 1064 patients were seen because of complaints relative to the breasts and 516 breast biopsies were done. Seventy patients were found to have cancer (14% of the breast biopsies). Using the October 1978 through March 1979 cost schedules for hospital and professional fees, the average cost of a breast biopsy was $1,216.00 for general anesthesia, $751.00 for assisted local anesthesia, and $520.00 for local anesthesia. The major differences lay in 1) anesthesia and operating room average charges of $618.00 for general anesthesia, $451.00 for assisted local anesthesia, and $260.00 for local anesthesia; 2) room charge of $174.00 for general anesthesia; and 3) laboratory and x-ray charges of $256.00 for general anesthesia, $120.00 for assisted local anesthesia, and $91.00 for local anesthesia. In 1978 64% of breast biopsies were done under local anesthesia as opposed to 1972 when 22% were done under local anesthesia. For the 516 breast biopsies, 47% were done under local anesthesia, 4% under assisted local anesthesia and 49% under general anesthesia. The calculated overall cost of the 516 breast biopsies was $448,794.00 or $6411.00 per cancer. Comparing our data to those of Lewis at our 1978-79 cost schedules and assuming our anesthetic mix in his patients, his cost per cancer identified was $3973.00 in patients with breast complaints. His cost figure is considerably lower than ours because of a higher yield of cancer (41%). Making the same assumptions for cost and anesthetic mix, the cost per biopsy proved cancer diagnosed in mammographic screening for breast cancer is $11,175.00 (Feig), and $24,482 (Lewis). Thus, 1) use of local anesthesia rather than general anesthesia reduces cost of breast biopsies by $694.00 per breast biopsy, 2) greater precision in selection of patients for breast biopsies is mandatory to reduce cost of diagnosis of cancer, 3) present state of the surgical art is more cost-effective than is screening for breast cancer.
第三方支付方进入医疗保健领域,使人们越来越意识到成本效益。由于乳房活检是最常进行的手术之一且备受争议,本报告的目的是提供与新墨西哥大学乳房活检成本效益相关的数据,并将这些数据与以下两项进行比较:1)乳腺癌乳房X线筛查的成本效益;2)对有乳房问题的患者合理使用乳房X线检查的成本效益。1972年至1978年期间,因乳房相关问题就诊的患者有1064例,进行了516例乳房活检。发现70例患有癌症(占乳房活检的14%)。根据1978年10月至1979年3月的医院和专业费用成本表,全身麻醉下乳房活检的平均成本为1216.00美元,辅助局部麻醉下为751.00美元,局部麻醉下为520.00美元。主要差异在于:1)全身麻醉的麻醉和手术室平均费用为618.00美元,辅助局部麻醉为451.00美元,局部麻醉为260.00美元;2)全身麻醉的病房费用为174.00美元;3)全身麻醉的实验室和X光检查费用为256.00美元,辅助局部麻醉为120.00美元,局部麻醉为91.00美元。1978年,64%的乳房活检在局部麻醉下进行,而1972年这一比例为22%。在516例乳房活检中,47%在局部麻醉下进行,4%在辅助局部麻醉下进行,49%在全身麻醉下进行。516例乳房活检的计算总成本为448,794.00美元,即每例癌症6411.00美元。按照1978 - 1979年的成本表将我们的数据与刘易斯的数据进行比较,并假设他的患者采用我们的麻醉组合,他在有乳房问题的患者中每确诊一例癌症的成本为3973.00美元。由于癌症检出率较高(41%),他的成本数字比我们的低得多。在成本和麻醉组合方面做出相同假设,乳腺癌乳房X线筛查中每例经活检确诊癌症的成本在费格的研究中为11,175.00美元,在刘易斯的研究中为24,482美元。因此,1)使用局部麻醉而非全身麻醉可使乳房活检成本每例降低694.00美元;2)必须更精确地选择进行乳房活检的患者以降低癌症诊断成本;3)目前的手术技术比乳腺癌筛查更具成本效益。